Monocular Vision Loss After Ear Filler Injection. | Canada Hyperbarics Skip to main content
Clinical Study Aesthetic plastic surgery 2025

Monocular Vision Loss After Ear Filler Injection.

Dong C, Chen CL, Wang HB — Aesthetic plastic surgery, 2025

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of monocular vision loss following hyaluronic acid filler injection into the ear.

What They Found

A 45-year-old woman experienced immediate left-sided vision loss after ear filler injection, diagnosed as central retinal artery occlusion with only the inferior temporal visual field remaining. Following treatment with hyaluronidase, dexamethasone, hyperbaric oxygen, and alprostadil, her vision improved with partial blood flow restoration in the left ophthalmic artery.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a single case report, this study's findings cannot be generalized to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Ocular / Retinal
Source Pubmed
PubMed ID 38388798
Year Published 2025
Journal Aesthetic plastic surgery
MeSH Terms Humans; Female; Middle Aged; Hyaluronic Acid; Dermal Fillers; Cosmetic Techniques; Retinal Artery Occlusion; Blindness; Risk Assessment; Treatment Outcome; Ophthalmic Artery; Follow-Up Studies

Cite This Study

Share

Find a Canadian Clinic Treating Ocular / Retinal

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology